Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
MabPlex is a one-stop outsourcing service provider for biopharmaceutical research and development and GMP production. The company mainly provides users with a series of biopharmaceutical research and development and production outsourcing services such as monoclonal antibody, recombinant protein, antibody drug coupling, etc. It can also provide the whole process solution of cytotoxin synthesis, linker production and coupling during antibody drug coupling ( ADC ) drug research and development

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 5 Competitors
Company Industry Series Amount Announced Date

LanssonPharm

LanssonPharm is a new drug research and development service provider, specializing in drug design, drug target identification, new drug structure design, pharmaceutical research, drug screening and evaluation and other fields, focusing on drug research and development of major diseases of the central nervous system, and carrying out drug informatics, new drug declaration, new drug policy consultation and other services

Healthcare

series A

Tens of millions CNY

28/1/2019

BociMed

BociMed is an enterprise engaged in drug research and development and clinical research. It provides high-quality research and development and outsourcing services including drug discovery, preclinical pharmaceutical research and development, clinical phase I-IV trials and registration declaration for enterprises through the establishment of a standardized service system

Healthcare

series B

Undisclosed

3/10/2020

Sciwind Biosciences

Sciwind Biosciences is a drug developer for metabolic diseases. The company is mainly engaged in the research of drugs for fatty hepatitis, liver fibrosis, liver cirrhosis and other related metabolic diseases, and involves the research and development of new biological drugs with independent intellectual property rights

Healthcare

series B

250 million CNY

19/2/2021

EUCURE BIOPARMA

EUCURE BIOPARMA is an innovative antibody drug developer with a monoclonal antibody preparation platform, in vivo efficacy detection platform, in vitro antibody analysis platform and so on. It mainly provides products such as tumor immune antibody drugs, tumor immune checkpoint antibodies and so on for users, involving targeting tumor, immune anti - cancer, cardiovascular and other diseases

Healthcare

series B

120 million CNY

27/3/2018

SINOMAB

SINOMAB is a research and development company for therapeutic antibody drugs. It applies proprietary antibody engineering patents and technology platforms to develop therapeutic antibody drugs for major diseases such as malignant tumors, autoimmune inflammatory diseases and infectious diseases

Healthcare

IPO

Hundreds of millions CNY

19/2/2019